Tebapivat Improves Red Cell Deformability and Decreases Sickling in Patients With Sickle Cell Disease: A Phase 1 Trial Substudy is a dataset published in European Journal Of Haematology (2025). On theSindex it has a DataRank of 0.165, placing it in the top 70.2% of the data-sharing corpus. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Ranks in the top 70% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →National Institutes of Health
Grant: KL2TR001856
Rigshospitalet Research Foundation
Grant: R246-A10854-B5622
AABB
FWCI
1.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords